Daidzin (Isoflavone Glycoside · Alcohol Craving Reduction · Cardiovascular)
| Compound | Daidzin |
| Chemical class | Polyphenol — Isoflavone Glycoside (Daidzein-7-O-glucoside) |
| CAS | 552-66-9 |
| Primary source | Glycine max (soybean), Pueraria lobata (kudzu root) |
| Key applications | Alcohol craving reduction, cardiovascular, phytoestrogenic |
| Claim strength | Moderate |
| Typical form | Kudzu root extract; soy isoflavones extract (glycoside fraction) |
| Buy from Herbuno |
Puerarin 98% Powder (Kudzu) | High-Purity Isolate | Pueraria lobata → Puerarin 40% Powder (Kudzu Extract) | Standardized Pueraria lobata → |
Name origin: Daidzin is the 7-O-glucoside of daidzein — the native glycoside form in which daidzein occurs in plant tissue. The name derives from the same Japanese/soy origin as daidzein. Traditional use: Kudzu root (Ge Gen) has been used in TCM for over 1,000 years for alcohol-related conditions, fever, cardiovascular disorders, and as a muscle relaxant for neck stiffness. Daidzin is one of the primary isoflavone glycosides responsible for kudzu’s pharmacological activity alongside puerarin. Research trajectory: Daidzin has attracted significant research for alcohol craving reduction and acetaldehyde metabolism modulation. Harvard/McLean Hospital research (Keung and Vallee) identified daidzin as a selective mitochondrial aldehyde dehydrogenase (ALDH-2) inhibitor, providing a mechanistic basis for kudzu’s traditional use in alcohol management. Commercial source: Daidzin is commercially available as a co-constituent of kudzu (Pueraria lobata) root extract alongside puerarin as the primary isoflavone glycosides. High-purity puerarin extract (98% and 40%) co-delivers daidzin. See sourcing options below.
Evidence for Daidzin Applications
Alcohol craving and consumption reduction: Daidzin selectively inhibits mitochondrial ALDH-2, causing accumulation of acetaldehyde after alcohol ingestion. In animal models this produces aversion to alcohol. Human pilot studies with kudzu extract (containing daidzin + puerarin) show reduced alcohol consumption per drinking episode without aversive effects at supplement doses. RCTs demonstrate reduced drinking intensity in heavy drinkers. Claim strength: Moderate.
Cardiovascular support: Daidzin and its metabolite daidzein contribute to the cardiovascular benefits of kudzu extract, including vasodilatory and lipid-modulating effects. TCM clinical studies (primarily Chinese literature) support kudzu isoflavone preparations for angina and hypertension management. Claim strength: Moderate.
Phytoestrogenic activity: As a glycoside, daidzin requires gut hydrolysis to daidzein before ER interaction. Phytoestrogenic activity is therefore indirect and microbiome-dependent, similar to the formononetin—daidzein pathway. Claim strength: Moderate.
Puerarin 98% Powder (Kudzu) | High-Purity Isolate | Pueraria lobata →
Puerarin 40% Powder (Kudzu Extract) | Standardized Pueraria lobata →
Browse Standardised Extract Powders →
Dosage & Formulator Specification
Alcohol management RCTs: kudzu extract at 1–3 g/day (containing combined daidzin + puerarin at 1–3% each), taken 30–60 minutes before drinking occasions. For Herbuno’s Puerarin 40% kudzu extract, 500–1000 mg/day delivers puerarin and co-present daidzin at pharmacologically relevant doses.
For isoflavone supplementation contexts: daidzin content in soy isoflavone extracts varies by whether the extract is specified as aglycone or glycoside form. Standard soy isoflavone extracts may contain up to 50% of isoflavone content as glycosides (genistin + daidzin + glycitin); aglycone-specified extracts have these pre-hydrolysed for improved bioavailability.
Daidzin has better water solubility than daidzein aglycone (glucose moiety improves solubility). However, gut hydrolysis to daidzein is required for absorption, making it microbiome-dependent. For consistent absorption, aglycone daidzein is pharmacokinetically preferable.
Frequently Asked Questions — Daidzin
Is daidzin from kudzu better than daidzein from soy for alcohol management?
The alcohol management evidence is specifically from kudzu extract, where daidzin and puerarin co-occur. Whether daidzin alone or the kudzu phytochemical matrix drives the effect is unresolved. The ALDH-2 inhibition mechanism is specific to daidzin (and its aglycone daidzein). Puerarin’s contribution to alcohol management is via different mechanisms. Kudzu extract as a whole is the most evidence-supported format for this application.
Does daidzin cause disulfiram-like reactions?
At supplement doses, daidzin does not produce the severe flushing and nausea associated with disulfiram (Antabuse). The ALDH-2 inhibition by daidzin is partial and selective for mitochondrial ALDH-2, not the cytosolic ALDH-1 that disulfiram inhibits. The practical effect at supplement doses is reduced alcohol tolerance and craving, not aversive disulfiram-type reactions.
Is kudzu root safe for long-term supplementation?
Kudzu root has a long history of human consumption in Asian cultures (food ingredient as well as medicine) and appears safe at traditional use levels. Long-term safety at concentrated isoflavone extract doses is not fully characterised. Phytoestrogenic effects should be considered for hormone-sensitive populations with the same advisory framework as other isoflavone supplements.
How does daidzin content in kudzu extract compare to soy isoflavone extract?
Kudzu root contains predominantly puerarin (daidzein-8-C-glucoside) as the primary isoflavone glycoside, with daidzin as a co-constituent. Soy contains daidzin (and genistin, glycitin) as the primary native glycosides. The specific isoflavone glycoside profile differs; puerarin is essentially absent from soy while daidzin is the shared compound between both botanicals.
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery